Dalal Street Investments
Top

Elder Pharma – Strong Dose of Results

May 6, 2008

Elder Pharma reported 32% YoY growth in top line in Q4FY08 on the back of strong performance of its leading brands. For full year FY08, total revenue increased by 22% YoY to Rs 5481.4 mn. The growth in revenues was mainly on account of strong performance by its leading brands like Shelcal, Chymoral, Eldervit etc.

Elder’s EBDITA margin remained stable at 20.2% during the fourth quarter ended March 2008. For full year FY08, EBDITA margin grew by 280 basis points to 20.2% as compared to 17.4% for last year.

Elder recorded 36.5% YoY growth at net profit level to Rs 204.2 mn during Q4FY08 compared to corresponding quarter last year. For FY08, net profit witnessed growth of 36.1% YoY to Rs 718 mn.

Comments

Got something to say?






Bottom